Home / Our research / Cerebral Tumour Research Laboratory 

Dr Kerrie McDonald

Level C Research Only Academic
Medicine, Northern Clinical School
Kolling Institute of Medical Research

T:+61 2 9926 4769
F:+61 2 9926 5708
E:

Publications

2009 | 2008 | 2007

2009

  
  • Elston, M., McDonald, K., Clifton-Bligh, R., Robinson, B. Familial pituitary tumor syndromes. Nature reviews. Endocrinology. 2009; 5:453-61. [Abstract]
  • Soon, P., Gill, A., Benn, D., Clarkson, A., Robinson, B., McDonald, K., Sidhu, S. Microarray gene expression and immunohistochemistry analyses of adrenocortical tumours identify IGF2 and Ki-67 as useful in differentiating carcinomas from adenomas. Endocrine-related cancer. 2009; 16:573-83. [Abstract]
  • Elston, M., Gill, A., Conaglen, J., Clarkson, A., Cook, R., Little, N., Robinson, B., Clifton-Bligh, R., McDonald, K. Nuclear accumulation of e-cadherin correlates with loss of cytoplasmic membrane staining and invasion in pituitary adenomas. The Journal of clinical Endocrinology and Metabolism. 2009; 94:1436-1442. [Abstract]

2008

  
Back to Top
  • Payne, C., Maleki, S., Messina, M., O'Sullivan, M., Stone, G., Hall, N., Parkinson, J., Wheeler, H., Cook, R., Biggs, M., Little, N., Teo, C., Robinson, B., McDonald, K. Loss of prostaglandin D2 synthase: a key molecular event in the transition of a low-grade astrocytoma to an anaplastic astrocytoma. Molecular Cancer Therapeutics. 2008; 7:3420-3428. [Abstract]
  • Au, A., McDonald, K., Gill, A., Sywak, M., Diamond, T., Conigrave, A., Clifton-Bligh, R. PTH Mutation with Primary Hyperparathyroidism and Undetectable Intact PTH. The New England journal of medicine. 2008; 359:1184-1186. [Abstract]
  • Fowler, A., Cook, R., Biggs, M., Little, N., Assaad, N., McDonald, K. Survival of patients following neurosurgical treatment of colorectal adenocarcinoma metastasis in the Northern Sydney-Central Coast area. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia. 2008; 15:998-1004. [Abstract]
  • Soon, P., McDonald, K., Robinson, B., Sidhu, S. Molecular markers and the pathogenesis of adrenocortical cancer. The Oncologist. 2008; 13:548-561. [Abstract]
  • Elston, M., Gill, A., Conaglen, J., Clarkson, A., Shaw, J., Law, A., Cook, R., Little, N., Clifton-Bligh, R., Robinson, B., McDonald, K. Wnt pathway inhibitors are strongly down-regulated in pituitary tumors. Endocrinology. 2008; 149:1235-42. [Abstract]
  • Parkinson, J., Wheeler, H., Clarkson, A., McKenzie, C., Biggs, M., Little, N., Cook, R., Messina, M., Robinson, B., McDonald, K. Variation of O(6)-methylguanine-DNA methyltransferase (MGMT) promoter methylation in serial samples in glioblastoma. Journal of neuro-oncology. 2008; 87:71-8. [Abstract]
  • Parkinson, J., Wheeler, H., McDonald, K. Contribution of DNA repair mechanisms to determining chemotherapy response in high-grade glioma. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia. 2008; 15:1-8. [Abstract]
  • Soon, P., Libe, R., Benn, D., Gill, A., Shaw, J., Sywak, M., Groussin, L., Bertagna, X., Gicquel, C., Bertherat, J., McDonald, K., Sidhu, S., Robinson, B. Loss of heterozygosity of 17p13, with possible involvement of ACADVL and ALOX15B, in the pathogenesis of adrenocortical tumors. Annals of Surgery. 2008; 247:157-164. [Abstract]

2007

  
Back to Top
  • Soon, P., Benn, D., Gill, A., Robinson, B., McDonald, K. Es07 microarray gene expression analysis of human adrenocortical tumours. Australia: Blackwell Publishing Asia, 2007. [Abstract]
  • McDonald, K., O'Sullivan, M., Parkinson, J., Shaw, J., Payne, C., Brewer, J., Young, L., Reader, D., Wheeler, H., Cook, R., Biggs, M., Little, N., Teo, C., Stone, G., Robinson, B. IQGAP1 and IGFBP2: valuable biomarkers for determining prognosis in glioma patients. Journal of neuropathology and experimental neurology. 2007; 66:405-417. [Abstract]